References
Hughes, A.I., Daniel, S.E., Kilford, L. & Lees, A.I. J. Neurol. Neurosurg. Psychiatry 55, 181–184 (1992).
Polymeropoulos, M.H. et al. Science 274. 1197–1199 (1996).
Polymeropoulos, M.H. et al. Science 276, 2045–2047 (1997).
George, J.M., Jin, H., Woods, W.S. & Clayton, D.F. Neuron 15, 361–372 (1995).
Spillantini, M.G. et al. Nature 388, 839–840 (1997).
Ueda, K. et al. Proc. Natl. Acad. Sci. USA 90, 11282–11286 (1993).
Weinreb, P.H., Zhen, W., Poon, A.W., Conway, K.A. & Lansbury Jr, P.T. Biochemistry 35, 13709–13715 (1996).
Iwai, A.A. et al. Neuron 14, 467–475 (1995).
Stryer, L. Freeman and Company, New York, (1988).
Scott, W.K. et al. Science 277, 387–388 (1997).
Gasser, T. et al. Science 277, 388–389 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, R., Kuhn, W., Müller, T. et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18, 106–108 (1998). https://doi.org/10.1038/ng0298-106
Issue Date:
DOI: https://doi.org/10.1038/ng0298-106
- Springer Nature America, Inc.
This article is cited by
-
Translational molecular imaging and drug development in Parkinson’s disease
Molecular Neurodegeneration (2023)
-
Calcineurin stimulation by Cnb1p overproduction mitigates protein aggregation and α-synuclein toxicity in a yeast model of synucleinopathy
Cell Communication and Signaling (2023)
-
Amelioration of olfactory dysfunction in a mouse model of Parkinson’s disease via enhancing GABAergic signaling
Cell & Bioscience (2023)
-
Knocking out alpha-synuclein in melanoma cells downregulates L1CAM and decreases motility
Scientific Reports (2023)
-
Ubiquilin-2 regulates pathological alpha-synuclein
Scientific Reports (2023)